Snai2 is associated with tumor development and aggressiveness by changing the gene expression of E-cadherin and VIM [54, 55], and functions as a direct inhibitor of E-cadherin by targeting the specific E-boxes of the E-cadherin proximal promoter [56]. The gene discussed is CDH1; the disease is neoplasm.